Biapenem/RPX 7009Alternative Names: RPX2003/RPX7009; RPX7009/biapenem; RPX7009/RPX2003
Latest Information Update: 14 Apr 2016
At a glance
- Originator Rempex Pharmaceuticals
- Class Antibacterials; Carbapenems; Small molecules
- Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gram-negative infections